Keyphrases
Orally Administered
100%
Obesity
100%
Cannabidiol
100%
Δ9-tetrahydrocannabinol (Δ9-THC)
100%
Oral Administration
25%
Weight Gain
25%
Endocannabinoids
25%
Adipose Tissue
25%
Steatosis
25%
Glucose Tolerance
25%
Liver
12%
Lipid Metabolism
12%
Male Mice
12%
C57BL
12%
Endocannabinoid System
12%
Oral Treatment
12%
Low Prevalence
12%
Cannabis Sativa
12%
Liver Tissue
12%
Rodent Models
12%
Route of Administration
12%
High Standards
12%
Diet-induced Obesity
12%
Obesity Prevalence
12%
High-fat Diet
12%
Anti-obesity
12%
2-Arachidonoylglycerol (2-AG)
12%
Metabolic Parameters
12%
Oral Consumption
12%
Morbid Obesity
12%
Cannabis Users
12%
Associated Comorbidities
12%
Tissue Adaptation
12%
Epididymal Tissue
12%
Medicine and Dentistry
Cannabidiol
100%
Tetrahydrocannabinol
100%
Adipose Tissue
42%
Oral Drug Administration
28%
Cannabis
28%
Endocannabinoid
28%
Steatosis
28%
Glucose Tolerance
28%
Lipid Metabolism
14%
Prevalence
14%
C57BL/6
14%
Endocannabinoid System
14%
Diet Induced Obesity
14%
Drug Administration Route
14%
Liver Tissue
14%
2 Arachidonoylglycerol
14%
Nabiximols
14%
Epididymal Tissue
14%
Comorbidity
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabidiol
100%
Tetrahydrocannabinol
100%
Endocannabinoid
28%
Steatosis
28%
Prevalence
14%
Cannabis
14%
Endocannabinoid System
14%
Cannabis Sativa
14%
Diet Induced Obesity
14%
Nabiximols
14%
2-Arachidonoylglycerol
14%
Comorbidity
14%